| 翻訳と辞書 |
Naluzotan
Naluzotan (INN, USAN; PRX-00023) is a serotonergic drug of the phenylpiperazine class that was under investigation by EPIX Pharmaceuticals Inc for the treatment of generalized anxiety disorder and major depressive disorder.〔 It acts as a selective and potent 5-HT1A receptor partial agonist,〔 readily stimulating prolactin responses, though it has also been found to bind to and activate the σ receptor. Naluzotan was well tolerated in clinical trials,〔 with more patients in the control group dropping out due to adverse effects than in the active group in one study.〔 The most frequently reported side effect was headache in 15% of patients (compared to 10% for placebo).〔 In addition, naluzotan demonstrated significant antidepressant and anxiolytic effects as per the HAM-D and MADRS and the HAM-A, respectively, in some trials,〔 but in others it did not. In the end it was not found to be significantly superior enough to placebo and development was stopped.〔
== See also ==
* Phenylpiperazine
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Naluzotan」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|